Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EXPAREL for Postsurgical Pain in Lumbar Spinal Fusion
NCT03015961Phase 4Terminated
- Sponsor
- Pacira BioSciences
- Start
- Feb 2017
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of liposomal bupivacaine in postoperative pain (2 arms), sponsored by Pacira BioSciences. Primary endpoint: Area Under the Curve of Visual Analog Scale Pain Intensity Scores. Started Feb 2017; status: terminated.
02
Drugs
liposomal bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03015961.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03015961.